Gene therapy - The best of times, the worst of times

被引：48

作者：

Anderson, WF ^{[1
]}

机构：

[1] Univ So Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90033 USA

来源：

SCIENCE | 2000年 / 288卷 / 5466期

关键词：

D O I：

10.1126/science.288.5466.627

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 [理学]; 0710 [生物学]; 09 [农学];

摘要：

[No abstract available]

引用

收藏

页码：627 / +

页数：2

相关论文

共 11 条

[1]

HUMAN GENE-THERAPY [J].

ANDERSON, WF .

SCIENCE, 1992, 256 (5058) :808-813

[2]

T-LYMPHOCYTE-DIRECTED GENE-THERAPY FOR ADA(-) SCID - INITIAL TRIAL RESULTS AFTER 4 YEARS [J].

BLAESE, RM ;

CULVER, KW ;

MILLER, AD ;

CARTER, CS ;

FLEISHER, T ;

CLERICI, M ;

SHEARER, G ;

CHANG, L ;

CHIANG, YW ;

TOLSTOSHEV, P ;

GREENBLATT, JJ ;

ROSENBERG, SA ;

KLEIN, H ;

BERGER, M ;

MULLEN, CA ;

RAMSEY, WJ ;

MUUL, L ;

MORGAN, RA ;

ANDERSON, WF .

SCIENCE, 1995, 270 (5235) :475-480

[3]

GENE-THERAPY IN PERIPHERAL-BLOOD LYMPHOCYTES AND BONE-MARROW FOR ADA(-) IMMUNODEFICIENT PATIENTS [J].

BORDIGNON, C ;

NOTARANGELO, LD ;

NOBILI, N ;

FERRARI, G ;

CASORATI, G ;

PANINA, P ;

MAZZOLARI, E ;

MAGGIONI, D ;

ROSSI, C ;

SERVIDA, P ;

UGAZIO, AG ;

MAVILIO, F .

SCIENCE, 1995, 270 (5235) :470-475

[4]

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease [J].

Cavazzana-Calvo, M ;

Hacein-Bey, S ;

Basile, CD ;

Gross, F ;

Yvon, E ;

Nusbaum, P ;

Selz, F ;

Hue, C ;

Certain, S ;

Casanova, JL ;

Bousso, P ;

Le Deist, F ;

Fischer, A .

SCIENCE, 2000, 288 (5466) :669-672

[5]

Hoogerbrugge PM, 1996, GENE THER, V3, P179

[6]

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization [J].

Isner, JM ;

Asahara, T .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1231-1236

[7]

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector [J].

Kay, MA ;

Manno, CS ;

Ragni, MV ;

Larson, PJ ;

Couto, LB ;

McClelland, A ;

Glader, B ;

Chew, AJ ;

Tai, SJ ;

Herzog, RW ;

Arruda, V ;

Johnson, F ;

Scallan, C ;

Skarsgard, E ;

Flake, AW ;

High, KA .

NATURE GENETICS, 2000, 24 (03) :257-261

[8]

ENGRAFTMENT OF GENE-MODIFIED UMBILICAL-CORD BLOOD-CELLS IN NEONATES WITH ADENOSINE-DEAMINASE DEFICIENCY [J].

KOHN, DB ;

WEINBERG, KI ;

NOLTA, JA ;

HEISS, LN ;

LENARSKY, C ;

CROOKS, GM ;

HANLEY, ME ;

ANNETT, G ;

BROOKS, JS ;

ELKHOUREIY, A ;

LAWRENCE, K ;

WELLS, S ;

MOEN, RC ;

BASTIAN, J ;

WILLIAMSHERMAN, DE ;

ELDER, M ;

WARA, D ;

BOWEN, T ;

HERSHFIELD, MS ;

MULLEN, CA ;

BLAESE, RM ;

PARKMAN, R .

NATURE MEDICINE, 1995, 1 (10) :1017-1023

[9]

T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates [J].

Kohn, DB ;

Hershfield, MS ;

Carbonaro, D ;

Shigeoka, A ;

Brooks, J ;

Smogorzewska, EM ;

Barsky, LW ;

Chan, R ;

Burotto, F ;

Annett, G ;

Nolta, JA ;

Crooks, G ;

Kapoor, N ;

Elder, M ;

Wara, D ;

Bowen, T ;

Madsen, E ;

Snyder, FF ;

Bastian, J ;

Muul, L ;

Blaese, RM ;

Weinberg, K ;

Parkman, R .

NATURE MEDICINE, 1998, 4 (07) :775-780

[10]

Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: Long-term expression in vivo of genes introduced with a retroviral vector [J].

Mullen, CA ;

Snitzer, K ;

Culver, KW ;

Morgan, RA ;

Anderson, WF ;

Blaese, RM .

HUMAN GENE THERAPY, 1996, 7 (09) :1123-1129